Home
Products
Technology
Usage
Technique Guide
Usage Cases
Efficiency
Researches
FAQ
Advantages
Articles
About us
Testimonials
News
Contacts
(067) 67 067 84
(048) 734 07 03
medivoinfo@gmail.com
UK
RU
EN
(067) 67 067 84
(048) 734 07 03
medivoinfo@gmail.com
UK
RU
EN
Home
Products
Technology
Usage
Technique Guide
Usage Cases
Efficiency
Researches
FAQ
Advantages
Articles
About us
Testimonials
News
Contacts
Usage
Researches
Pilot Hemostatic Performance of MIRRAGEN
Pilot Hemostatic Performance of MIRRAGEN
Collaboration with OHSU, Dr. Schreiber, Chief, Division of Trauma,
Critical Care and Acute Care Surgery
Objective: Utilize the Thrombelastograph (TEG) to examine the hemostatic properties of each test agent in vitro.
MIRRAGEN(formerly known as DermaFuse)
Whole Blood
Combat Gauze
Kerlix
Dr. Schreiber
Chief, Division of Trauma, Critical Care and Acute Care Surgery
(OHSU)
Pilot Hemostatic Performance of MIRRAGEN
Hemostatic Performance of MIRRAGEN
Reactiontime, Minutes Time For Initial Fibrin
Clot Formation
Maximum Amplitude (Millimeters)
Maximum Clot Strength or Firmness
Percent Lysis at 30 min
Post MaxClot Strength
Coagulation Index, CI
Overall Coagulation
Reaction time; R, min
— the time that the initial fibrin formation is detected
Clotting time; K, min
— the speed of clot formation and is the time from the R time until a clot with a fixed firmness is formed
Angle; a, degree
— the kinetics of clot development
Maximum amplitude; MA, mm
— the maximum strength or firmness of the developed clot
Coagulation index; CI
— overall coagulation
LY30
— percent lysis at 30 min post maximum clot strength
Pilot Study performed® OHSU, Division of Trauma and Acute Care Surgery n=2/group
Hemostatic Performance of MIRRAGEN
Antibacterial Testing of MIRRAGEN
Preliminary USP 51
Organism
Log Reduction
A. brasiliensis (ATCC 16404)
6.04
E. coli (ATCC 8739)
5.93
C. albicans (ATCC 10231)
5.91
P. aeruginosa (ATCC 9027)
6.08
S. aureus (ATCC 6538)
5.5
Extraordinary Results: > 5.5 Log Reduction within 14 days
Antibacterial Testing of MIRRAGEN
Table 8.3 Log10 Reduction of Recovered Micro-organisms
Report 18-0590-1088
*Cells Highlighted in Red indicate >4-Log10 (99.99%) reduction in recovered bacteria
Table 8.3 Log10 Reduction of Recovered Micro-organisms
Table 8.4 % Killing of Recovered Micro-organisms
Report 18-0590-1088
Table 8.4 % Killing of Recovered Micro-organisms